Clinical Trial Update: Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma. [Phase 1]

View source ↗

Summary

Phase 1 trial of the multi-kinase inhibitor TG02 in elderly newly diagnosed or adult relapsed patients with anaplastic astrocytoma or glioblastoma has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• TG02

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Astrocytoma, Grade III, Glioblastoma | Phase 1 | Status: COMPLETED | Results posted: 2025-11-26